Lantheus has filed what it says is the first generic version of Novartis’ big-selling cancer radionuclide therapy Lutathera in the US, used to treat rare neuroendocrine tumours (NETs). The FDA has ...

A federal appeals court in the US has declined to overturn an attempt by Novartis to block the launch of a generic version of its blockbuster heart failure drug Entresto. The US Court of Appeals for ...

Follow Cointelegraph’s comprehensive coverage of the SEC’s spot Ether ETF decision. Get the latest news on the ETH ETF approval, a milestone in the crypto industry. Stay informed with exclusive ...

Farran Powell is the managing editor of investing at Forbes Advisor. She was previously the assistant managing editor of investing at U.S. News & World Report. Her work has appeared in numerous ...

How and when will life on Earth end? Study may have found the answers ...